solid standards and rules for newly-regulated products will follow the new federal approach to regulate nicotine.
“[The key is] understanding the short-term impacts of tobacco use and also the decision-making process by which people smoke and how they perceive risks,” Glantz added. “When the FDA does rulemaking, they do cost benefit analyses and those analyses are heavily conditioned on what we think are incorrect assumptions about the way people make decisions about tobacco. This also ignores the shorter-term impact of tobacco use, which has a big effect on the overall cost. We’re trying to develop better models of economic and behavioral as well as health impacts of tobacco use that would help the FDA build better models.”
The FDA is expected to release guidelines describing how the new policies will be enforced shortly.